Ms. Tammy Brady, DISPENSING NURSE Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 242 S Main St, Saint Albans, VT 05478 Phone: 802-370-3545 Fax: 802-524-0055 |
Ms. Sarah J Holm, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 242 S Main St, Saint Albans, VT 05478 Phone: 802-370-3545 Fax: 802-524-0055 |
Jane Elizabeth Robison, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 242 S Main St, Saint Albans, VT 05478 Phone: 802-370-3545 |
Tina M Mclaughlin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 242 S Main St, Saint Albans, VT 05478 Phone: 802-370-3545 Fax: 802-524-0055 |
Mrs. Elizabeth Anne Green, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 242 S Main St, Saint Albans, VT 05478 Phone: 802-777-9323 |
News Archive
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed an exclusive distribution agreement with Nihon-Kohden, Japan's leading manufacturer, developer and distributor of medical electronic equipment . The agreement allows Nihon-Kohden the exclusive right to distribute Z-Medica's QuikClot line of hemostatic agents to hospital, military and law enforcement markets throughout Japan. The companies have been working together since early 2009 to obtain regulatory approval.
If North Carolina reflects what is happening nationally, most pediatricians across the country lack confidence in their ability to treat obesity, which is increasingly recognized as robbing children of physical vigor now and good health in later life, a new study shows.
Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.
In the most comprehensive international comparison of its kind, a USC study found that the United States has the highest drug overdose death rates among a set of high-income countries.
Eli Lilly & Co did not win the support of the U.S. advisory panel on Wednesday for its one-of-its kind drug not made from pig enzymes to help certain pancreatic patients digest food. A Food and Drug Administration panel of outside experts in a 7-4 vote said they were not convinced the experimental medicine, known chemically as liprotamase, worked well enough for patients to absorb enough needed nutrients. One member of the panel abstained.
› Verified 7 days ago